2023
DOI: 10.3390/healthcare11212881
|View full text |Cite
|
Sign up to set email alerts
|

Machine Learning for Sarcopenia Prediction in the Elderly Using Socioeconomic, Infrastructure, and Quality-of-Life Data

Minje Seok,
Wooseong Kim,
Jiyoun Kim

Abstract: Since the WHO’s 2021 aging redefinition emphasizes “healthy aging” by focusing on the elderly’s ability to perform daily activities, sarcopenia, which is defined as the loss of skeletal muscle mass, is now becoming a critical health concern, especially in South Korea with a rapidly aging population. Therefore, we develop a prediction model for sarcopenia by using machine learning (ML) techniques based on the Korea National Health and Nutrition Examination Survey (KNHANES) data 2008–2011, in which we focus on t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 69 publications
0
2
0
Order By: Relevance
“…A study in patients with liver cell cancer, however, also found a correlation between sarcopenia and HRQoL in a prospective study [ 70 ]. Similarly, a recent study on machine learning used QoL as one of three factors to establish a prediction model of sarcopenia [ 71 ]. This association of sarcopenia and HRQoL is important, as the presence of sarcopenia is associated with adherence to prescribed chemotherapy regimens and the occurrence of dose-limiting toxicity during neoadjuvant chemotherapy [ 31 , 72 , 73 ].…”
Section: Discussionmentioning
confidence: 99%
“…A study in patients with liver cell cancer, however, also found a correlation between sarcopenia and HRQoL in a prospective study [ 70 ]. Similarly, a recent study on machine learning used QoL as one of three factors to establish a prediction model of sarcopenia [ 71 ]. This association of sarcopenia and HRQoL is important, as the presence of sarcopenia is associated with adherence to prescribed chemotherapy regimens and the occurrence of dose-limiting toxicity during neoadjuvant chemotherapy [ 31 , 72 , 73 ].…”
Section: Discussionmentioning
confidence: 99%
“…While some studies use a combination of metrics such as SARC-F, others independently leverage specific metrics for diagnosing sarcopenia [ 16 , 18 , 20 ]. Additionally, studies have explored indirect prediction of sarcopenia through patient data [ 5 , 11 , 12 ], often employing feature selection to identify causative factors, yielding varying results in features and accuracy [ 21 , 22 ].…”
Section: Methodsmentioning
confidence: 99%